BioSpecifics Technologies Corp. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced total revenue was USD 3.903 million compared to USD 8.852 million a year ago. Operating loss was USD 250,920 compared to operating Income of USD 6.963 million a year ago. Net income was USD 115,796 compared to USD 6.426 million a year ago. Basic earnings per share was USD 0.02 compared to USD 0.88 a year ago. Diluted earnings per share was USD 0.02 compared to USD 0.87 a year ago. For the half year, total revenue was USD 13.572 million compared to USD 16.982 million a year ago. Operating income was USD 4.981 million compared to USD 12.035 million a year ago. Net income was USD 4.614 million compared to USD 10.843 million a year ago. Basic earnings per share was USD 0.63 compared to USD 1.49 a year ago. Diluted earnings per share was USD 0.63 compared to USD 1.48 a year ago.